Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 18 EP applications Rebecca Marie Tollervey has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11849944

MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF

IPC classification:
C12N 15/44, A61K 39/145
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12835033

RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS

IPC classification:
A61K 39/155
Agent:
Cooley (UK) LLP
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14170551

Methods for genetic analysis

IPC classification:
C12Q 1/68
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
The patent has been granted
EP13791616

CARRIERS FOR IMPROVED DRUG DELIVERY

IPC classification:
A01N 43/42, A01N 25/00, C08F 12/28
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13807804

PURIFICATION OF VIRUS LIKE PARTICLES

IPC classification:
A61K 39/125, C12N 7/02
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13785801

NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY

IPC classification:
G01N 33/50
Applicant:
Winthrop-University Hospital
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Agent:
Rentsch Partner AG
Status:
The patent has been granted
EP13711221

EFFICIENT COMPARISON OF POLYNUCLEOTIDE SEQUENCES

IPC classification:
G06F 19/22
Applicant:
Illumina, Inc.
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13165622

Cell sheet having good dimensional stability, method for production thereof, and cell culture carrier for use in the method

IPC classification:
C12N 5/00
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16160404

TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE

IPC classification:
G01N 33/68, G01N 33/92
Applicant:
The Cleveland Clinic Foundation
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP17155514

METHODS FOR VIRAL INACTIVATION AND OTHER ADVENTITIOUS AGENTS

IPC classification:
C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The application has been published
EP15857562

HAND, FOOT, AND MOUTH VACCINES AND METHODS OF MANUFACTURE AND USE THEREOF

IPC classification:
C12N 15/41
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP15852241

THERAPEUTIC VITAMIN D CONJUGATES

IPC classification:
A61K 38/22, A61K 47/60
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP16749976

METHODS FOR PRODUCING VIRUS FOR VACCINE PRODUCTION

IPC classification:
C12N 7/00
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP17174600

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

IPC classification:
A61K 47/68, G01N 33/574, C07K 16/30, A61K 31/537, A61K 45/06, A61K 38/05, A61K 39/00, A61K 51/10, A61P 35/00, C12N 15/13, A61K 39/395, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
The application has been published
EP16777311

ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
C12N 5/02, A61K 38/12, A61K 31/7088, A61K 39/395
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP16787238

MODULATION OF IMMUNE RESPONSE USING BTLA AGONIST ANTIBODIES

IPC classification:
A61K 39/395
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made
EP18151284

ALPHA-AMYLASE CONBINATORIAL VARIANTS

IPC classification:
C11D 3/386, C12N 9/26
Applicant:
Danisco US Inc.
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
The application has been published
EP16760335

ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00, A61P 35/00, A61P 25/00, C07K 16/28
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature